Login
$NEPH
$3.51 -$0.12 (3.31%) Close

$NEPH 4/A SEC Filings

Filed On Filing
01 Jun 2021 Form 4/A: Evans Daron, CEO Specialty Renal Products

Gave up 698 shares to cover exercise price or tax ($1.88K)

02 May 2019 Form 4/A: Lask Alisa, Director

Granted 86,546 Stock Option (right to buy)

20 Dec 2018 Form 4/A: Pinto Moshe, Director

Received 47,673 shares as a grant or award

27 Feb 2018 Form 4/A: Pinto Moshe, Director

Received 73,864 shares as a grant or award · Granted 40,284 Stock Option (Right to Buy)

15 May 2017 Form 4/A: Astor Andrew, Chief Financial Officer

Granted 209,355 Stock Option (right to buy)

05 Jun 2013 Form 4/A: Lambda Investors Llc, 10% owner and 4 others

Bought 2,992,884 shares · Received 46,692 shares as a grant or award

05 Nov 2008 Form 4/A: Enso Capital Management Llc, 10% owner and 3 others

Sold 29,867 shares ($7.28K)

05 Nov 2008 Form 4/A: Enso Capital Management Llc, 10% owner and 3 others

Sold 0 shares (—)

12 Apr 2005 Form 4/A: Barta Norman J, Director

Bought 1,100 shares ($3.45K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support